Literature DB >> 25696016

Congenital peribronchial myofibroblastic tumor: case report of an asymptomatic infant with a rapidly enlarging pulmonary mass and review of the literature.

Katharine E Brock1, James Wall2, Micaela Esquivel3, Beverley Newman4, Neyssa Marina5, Craig Albanese2, Florette K Hazard6.   

Abstract

BACKGROUND: Congenital peribronchial myofibroblastic tumor (CPMT) is a rare, benign lung tumor of infants, with only 19 reported cases worldwide. It is often diagnosed by prenatal imaging or in the immediate postnatal period due to co-morbidities like polyhydramnios, fetal hydrops, respiratory distress, and heart failure. OBSERVATION: We report the oldest known infant (8 weeks old) diagnosed with CPMT, and present his clinical course including the relevant radiographic and histopathologic findings.
CONCLUSIONS: CPMT is a rare tumor that should be considered among other primary lung tumors of infancy (developmental, benign, and malignant) even if not detected prenatally or in the immediate postnatal period.
© 2015 by the Association of Clinical Scientists, Inc.

Entities:  

Keywords:  benign lung tumor; congenital peribronchial myofibroblastic tumor; neonatal; pleuropulmonary blastoma

Mesh:

Year:  2015        PMID: 25696016

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  3 in total

1.  Neonatal congenital lung tumors - the importance of mid-second-trimester ultrasound as a diagnostic clue.

Authors:  Stephan L Waelti; Laurent Garel; Dorothée Dal Soglio; Françoise Rypens; Michael Messerli; Josée Dubois
Journal:  Pediatr Radiol       Date:  2017-09-07

Review 2.  Magnetic resonance imaging for congenital lung malformations.

Authors:  Beverley Newman
Journal:  Pediatr Radiol       Date:  2021-03-10

3.  A Congenital Peribronchial Myofibroblastic Tumor Detected in a Premature Infant at 28 Weeks but That Resolved in the Late Stage of Pregnancy: A Case Report.

Authors:  Bo Xia; Gang Yu; Chun Hong; Lei Zhang; Jing Tang; Cuifen Liu
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.